APA (7th ed.) Citation

Vonk, C. M., Boertjes, E. L., Kavelaars, F. G., Rijken, M., Konijnenburg, J. M. L., Cromwell, R. E., . . . Valk, P. J. M. (2024, August). Prognostic relevance of molecular measurable residual disease detection in AML with mutated CEBPA. HemaSphere.

Chicago Style (17th ed.) Citation

Vonk, Christian M., Emma L. Boertjes, Francois G. Kavelaars, Melissa Rijken, Jolinda M. L. Konijnenburg, Roxanne E. Cromwell, Bob Löwenberg, Tim Grob, and Peter J. M. Valk. "Prognostic Relevance of Molecular Measurable Residual Disease Detection in AML with Mutated CEBPA." HemaSphere Aug. 2024.

MLA (9th ed.) Citation

Vonk, Christian M., et al. "Prognostic Relevance of Molecular Measurable Residual Disease Detection in AML with Mutated CEBPA." HemaSphere, Aug. 2024.